Systematized Review of Psychotherapeutic Components of Psilocybin-Assisted Psychotherapy
David Horton, Blaise Morrison, Judy A. Schmidt
American Journal of Psychotherapy July 23, 2021 DOI: 10.1176/appi.psychotherapy.20200055 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematized review Peer reviewed |
|---|---|
| Duration | Past 25 years |
| Topics | Psilocybin Psychedelic-assisted therapy |
| Keywords | Psychotherapist Psycinfo Clinical trial Clinical psychology Medline |
| Citations | 92 |
| Key findings | Important commonalities exist among clinical trials of PAP, but key differences in how psychotherapy is incorporated into PAP remain, and more research is needed to identify the unique effect of psychotherapy. |
Abstract
This systematized review found important commonalities among clinical trials of PAP published within the past 25 years and revealed key differences among studies in psychotherapy's incorporation into PAP. Additional research is needed to identify the unique effect of psychotherapy in PAP.
Comparable studies
Other narrative reviews on psilocybin and psychedelic-assisted therapy, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development | 2018 | Review | |
| Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA. | 2016 | Review | |
| The Emerging Field of Psychedelic Psychotherapy. | 2022 | Review | |
| Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications Participants in psychedelic therapy research aged 18–69 with varied backgrounds | 2020 | Rapid review | n = 180 |
| Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness. Palliative care clinicians and patients | 2022 | Review |